Literature DB >> 11353578

Role of central mineralocorticoid receptors in cardiovascular disease.

C E Gomez-Sanchez1, E P Gomez-Sanchez.   

Abstract

Mineralocorticoids act directly through their receptors in specific centers in the central nervous system, kidneys, heart, and vascular smooth muscle to mediate hemodynamic homeostasis. These steroids also modulate renal and cardiovascular function indirectly through the autonomic nervous system. Complex homeostatic mechanisms under normal hormonal control become pathogenic when there is an excess of regulatory hormone. Experiments in which mineralocorticoid receptor antagonists or antisense oligodeoxynucleotides were administered centrally have clearly shown that centrally mediated effects on salt appetite, baroreceptor function, and autonomic drive to the renal and cardiovascular systems are crucial to the pathogenesis of hypertension and cardiovascular disease of hyperaldosteronism, and certain forms of genetic hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353578     DOI: 10.1007/s11906-001-0049-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  76 in total

1.  Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension.

Authors:  M Nishimura; K Ohtsuka; H Takahashi; M Yoshimura
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

2.  Impaired baroreflex function and arterial compliance in primary aldosteronism.

Authors:  F Veglio; P Molino; G Cat Genova; R Melchio; F Rabbia; T Grosso; G Martini; L Chiandussi
Journal:  J Hum Hypertens       Date:  1999-01       Impact factor: 3.012

Review 3.  Molecular properties of epithelial, amiloride-blockable Na+ channels.

Authors:  H Garty
Journal:  FASEB J       Date:  1994-05       Impact factor: 5.191

4.  Steroid receptor heterodimerization demonstrated in vitro and in vivo.

Authors:  W Liu; J Wang; N K Sauter; D Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  Transcriptional regulation of the human Na/K ATPase via the human mineralocorticoid receptor.

Authors:  V Kolla; G Litwack
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

6.  Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.

Authors:  D T van den Berg; E R de Kloet; H H van Dijken; W de Jong
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

7.  Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone.

Authors:  E P Gomez-Sanchez; C E Gomez-Sanchez
Journal:  Am J Physiol       Date:  1992-12

8.  Localization of 11beta-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies.

Authors:  B L Roland; J W Funder
Journal:  Endocrinology       Date:  1996-03       Impact factor: 4.736

9.  Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene.

Authors:  H Tamura; L Schild; N Enomoto; N Matsui; F Marumo; B C Rossier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats.

Authors:  C A Bruner; M L Mangiapane; G D Fink; R C Webb
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

View more
  2 in total

1.  Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension.

Authors:  Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Maria Plonczynski; Celso E Gomez-Sanchez
Journal:  Exp Physiol       Date:  2009-10-16       Impact factor: 2.969

2.  Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.

Authors:  Yongzhong Wei; Adam T Whaley-Connell; Javad Habibi; Jenna Rehmer; Nathan Rehmer; Kamlesh Patel; Melvin Hayden; Vincent DeMarco; Carlos M Ferrario; Jamal A Ibdah; James R Sowers
Journal:  Hypertension       Date:  2008-12-29       Impact factor: 10.190

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.